Company · CIK 0001601830 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
RECURSION PHARMACEUTICALS, INC. · RXRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 FForm 4 → | Sep 16, 5:52 pm EDT | Ben R TaylorChief Financial Officer | 5,396 | $3.41 | $18,400 | 1,071,462 | — | |
| Sep 8, 2026 SForm 4 → | Sep 10, 5:55 pm EDT | Najat KhanCEO and President, Director | 22,408 | $3.52 | $78,822 | 2,072,890 | −1.07% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 2, 6:01 pm EDT | Blake BorgesonDirector | 30,000 | $3.34 | $100,200 | 6,158,287 | −0.48% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.